Tenet Healthcare Corporation (NYSE:THC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Tenet Healthcare Corporation (NYSE:THC) have received a consensus recommendation of “Moderate Buy” from the twenty-two analysts that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $244.3158.

Several analysts have issued reports on the stock. Robert W. Baird lowered their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Mizuho raised their price target on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. KeyCorp lowered their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Royal Bank Of Canada reduced their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Finally, Morgan Stanley set a $254.00 target price on Tenet Healthcare in a research report on Friday, May 1st.

Tenet Healthcare Trading Up 0.3%

NYSE:THC opened at $204.28 on Friday. The business’s 50-day moving average is $181.48 and its two-hundred day moving average is $197.31. The firm has a market capitalization of $17.60 billion, a PE ratio of 10.62, a price-to-earnings-growth ratio of 1.68 and a beta of 1.27. Tenet Healthcare has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Research analysts predict that Tenet Healthcare will post 17.61 earnings per share for the current fiscal year.

Insider Transactions at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of the stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.97% of the company’s stock.

Institutional Trading of Tenet Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of THC. Triumph Capital Management acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $25,000. Activest Wealth Management bought a new position in Tenet Healthcare in the fourth quarter worth about $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare in the fourth quarter valued at approximately $29,000. Canada Pension Plan Investment Board bought a new position in shares of Tenet Healthcare during the second quarter valued at approximately $35,000. Finally, Meeder Asset Management Inc. lifted its holdings in shares of Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.